Health Regulators-Artificial Hips-Hip Implants-Metal Ball

Safety of all-metal hip implants under scrutiny

WASHINGTON (Reuters) - As concerns mount over the safety of metal-on-metal hip implants, health regulators are seeking advice on how best to minimize risks for the more than 500,000 patients who have received the devices. All-metal artificial hips were developed to be more durable than traditional implants, which combine a ceramic or metal ball with a plastic socket. Johnson & Johnson is the biggest manufacturer of the all-metal devices, and other device makers include Zimmer Holdings Inc and Wright Medical Group. ... read more..

source:http://yhoo.it/Os5gIx

Food And Drug Administration-Blood Clot Preventer-Bristol-Myers Squibb-Health Regulators

Bristol/Pfizer clot preventer delayed in U.S

(Reuters) - A closely watched blood clot preventer from Bristol-Myers Squibb Co and Pfizer Inc has failed to win approval from U.S. health regulators, the companies said on Monday. Investors have been awaiting a decision on the drug, Eliquis, by the Food And Drug Administration by the end of the month. The FDA notification did not require the companies to complete any new studies, the companies said, which could mean only a short delay before the drug wins approval. Rather, the agency wants more information on data management and verification from a key clinical trial supporting the medicine. ... read more..

source:http://yhoo.it/MmEDll

Food And Drug Administration-Swiss Pharmaceutical Company-Blockbuster Cancer Drug

Roche's breast cancer drug gets FDA nod

Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz

(Reuters) - U.S. health regulators have approved a new breast cancer drug from Roche Holding AG that the company hopes will become the standard treatment for women with an aggressive, incurable form of cancer. Roche unit Genentech announced Friday that the Food and Drug Administration approved the injectable drug Perjeta for women with a type of breast cancer known as HER-2 positive, which makes up about a quarter of all breast cancers and has no cure. Analysts predict the medicine could be another blockbuster cancer drug for the Swiss company. ... read more..

source:http://yhoo.it/Ms612a

American Cancer Society-Health Regulators-Prostate Cancer-Cancer Therapy-Loud Protests

Insight: New doubts about prostate-cancer vaccine Provenge

NEW YORK (Reuters) - Prostate cancer vaccine Provenge has long incited passions unlike any other cancer therapy. Doctors who raised doubts about it received death threats. Health regulators and lawmakers faced loud protests at their offices. A physician at the American Cancer Society was so intimidated by Provenge partisans that he yanked a skeptical discussion of it from his blog. The vitriol dissipated in April 2010, when the U.S. ... read more..

source:http://yhoo.it/H7SMRY

Birth Control Pills-Contraceptive Drugs-Health Regulators-Blood Clots

FDA favors more risk info on birth control pills

Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed Birth Control pills such as Yaz, in light of growing evidence that the newer contraceptive drugs may be riskier than older drugs. read more..

source:http://yhoo.it/uYQpFo